- Home
- ELMD vs CRBP Comparison
ELMD vs CRBP Comparison
Compare ELMD & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELMD
- CRBP
- Stock Information
- Founded
- ELMD 1992
- CRBP 2009
- Country
- ELMD United States
- CRBP United States
- Employees
- ELMD N/A
- CRBP N/A
- Industry
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CRBP Biotechnology: Pharmaceutical Preparations
- Sector
- ELMD Health Care
- CRBP Health Care
- Exchange
- ELMD Nasdaq
- CRBP Nasdaq
- Market Cap
- ELMD 201.5M
- CRBP 210.8M
- IPO Year
- ELMD 2010
- CRBP N/A
- Fundamental
- Price
- ELMD $26.71
- CRBP $11.91
- Analyst Decision
- ELMD Strong Buy
- CRBP Strong Buy
- Analyst Count
- ELMD 2
- CRBP 9
- Target Price
- ELMD $36.00
- CRBP $48.38
- AVG Volume (30 Days)
- ELMD 49.5K
- CRBP 534.9K
- Earning Date
- ELMD 11-12-2025
- CRBP 11-12-2025
- Dividend Yield
- ELMD N/A
- CRBP N/A
- EPS Growth
- ELMD 30.89
- CRBP N/A
- EPS
- ELMD 0.94
- CRBP N/A
- Revenue
- ELMD $66,218,999.00
- CRBP N/A
- Revenue This Year
- ELMD $14.47
- CRBP N/A
- Revenue Next Year
- ELMD $10.33
- CRBP $220.00
- P/E Ratio
- ELMD $28.21
- CRBP N/A
- Revenue Growth
- ELMD 16.05
- CRBP N/A
- 52 Week Low
- ELMD $17.73
- CRBP $4.64
- 52 Week High
- ELMD $35.56
- CRBP $20.56
- Technical
- Relative Strength Index (RSI)
- ELMD 58.15
- CRBP 44.86
- Support Level
- ELMD $24.29
- CRBP $11.06
- Resistance Level
- ELMD $28.00
- CRBP $12.43
- Average True Range (ATR)
- ELMD 1.09
- CRBP 0.72
- MACD
- ELMD 0.20
- CRBP 0.10
- Stochastic Oscillator
- ELMD 62.79
- CRBP 77.87
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.